Lunai Bioworks Inc.
LNAI · Pharmaceutical Preparations
Latest available SEC filing: 10-K ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13D/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
William Anderson Wittekind: Form 4
Insider disclosure · Filed · Report period 10 Mar 2025
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001527728 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LNAI on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Century City Medical Plaza, 2080 Century City East, Suite 906 Los Angeles, CA, 90067
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
-
RENOVARO INC. (to 26 Aug 2025) RENOVARO BIOSCIENCES INC. (to 07 Feb 2024) Enochian Biosciences Inc (to 01 Aug 2023) DanDrit Biotech USA Inc. (to 23 Feb 2018) Putnam Hills Corp. (to 11 Feb 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields